ArticleCureus2025
Combination of Mpox With Ocular Involvement, Human Immunodeficiency Virus, and Pulmonary Tuberculosis Resulting in High Mortality: A Report of Two Cases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mpox is a reemerging zoonotic viral disease that has been declared a public health emergency. Ocular symptoms of mpox include pain, redness, tearing, discharge, swelling, and vision impairment. This report describes two cases of mpox with ocular involvement in Indonesia, where the patients had a history of multiple male partners (men who have sex with men (MSM)), human immunodeficiency virus (HIV), and tuberculosis (TB). The first case was a 28-year-old male patient with multiple scabs, including in the eye area, shown as right-eye blepharoconjunctivitis. Despite treatment with tecovirimat, he died from respiratory failure. The second case involved a 25-year-old male patient with similar symptoms and blepharoconjunctivitis in both eyes. He did not receive tecovirimat and also died from respiratory failure. Mpox can severely affect organs, including the eyes. The risk of mpox fatality increases with HIV and TB co-infection. Early recognition of the disease signs may improve the prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.